| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 153 | 2024 | 3387 | 14.320 |
Why?
|
| Stem Cell Niche | 41 | 2022 | 346 | 8.840 |
Why?
|
| Bone Marrow | 55 | 2024 | 2912 | 5.220 |
Why?
|
| Bone Marrow Cells | 62 | 2024 | 2414 | 5.050 |
Why?
|
| Hematopoiesis | 57 | 2024 | 2050 | 4.640 |
Why?
|
| Stromal Cells | 20 | 2024 | 1326 | 2.840 |
Why?
|
| Leukemia, Myeloid, Acute | 19 | 2022 | 3602 | 2.600 |
Why?
|
| Osteoblasts | 25 | 2019 | 1142 | 2.540 |
Why?
|
| Thymus Gland | 16 | 2023 | 1247 | 2.530 |
Why?
|
| Sarcoma, Kaposi | 28 | 2012 | 376 | 2.300 |
Why?
|
| Stem Cells | 26 | 2023 | 3523 | 2.250 |
Why?
|
| Cell Differentiation | 69 | 2024 | 11481 | 2.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 30 | 2008 | 2197 | 1.780 |
Why?
|
| Mice | 183 | 2024 | 81208 | 1.730 |
Why?
|
| Animals | 236 | 2024 | 167963 | 1.690 |
Why?
|
| Thymectomy | 2 | 2023 | 194 | 1.680 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 33 | 2024 | 5649 | 1.660 |
Why?
|
| Cell Lineage | 30 | 2021 | 2533 | 1.630 |
Why?
|
| Leukemia | 15 | 2022 | 1520 | 1.570 |
Why?
|
| Mesenchymal Stem Cells | 16 | 2019 | 1634 | 1.500 |
Why?
|
| Lymphoma, AIDS-Related | 12 | 2008 | 79 | 1.470 |
Why?
|
| Neoplastic Stem Cells | 16 | 2015 | 1347 | 1.440 |
Why?
|
| Adult Stem Cells | 7 | 2020 | 221 | 1.390 |
Why?
|
| Cell Cycle | 22 | 2023 | 2934 | 1.170 |
Why?
|
| Myeloid Cells | 11 | 2021 | 820 | 1.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 15 | 2021 | 629 | 1.120 |
Why?
|
| Antigens, CD34 | 23 | 2011 | 653 | 1.100 |
Why?
|
| Bone Marrow Transplantation | 14 | 2020 | 2693 | 1.090 |
Why?
|
| Cell Separation | 13 | 2016 | 1720 | 1.060 |
Why?
|
| Monocytes | 15 | 2023 | 2575 | 1.050 |
Why?
|
| Lymphopoiesis | 5 | 2019 | 133 | 1.030 |
Why?
|
| Stem Cell Transplantation | 10 | 2016 | 1599 | 1.030 |
Why?
|
| Bone and Bones | 12 | 2020 | 2560 | 1.020 |
Why?
|
| Regenerative Medicine | 4 | 2019 | 307 | 1.020 |
Why?
|
| Tumor Microenvironment | 12 | 2024 | 3844 | 1.020 |
Why?
|
| Herpesvirus 8, Human | 13 | 2007 | 255 | 1.000 |
Why?
|
| Cell Movement | 27 | 2021 | 5206 | 1.000 |
Why?
|
| Mice, Inbred C57BL | 61 | 2024 | 22023 | 0.960 |
Why?
|
| Hematologic Neoplasms | 7 | 2019 | 1895 | 0.930 |
Why?
|
| Sympathetic Nervous System | 6 | 2016 | 520 | 0.890 |
Why?
|
| Single-Cell Analysis | 7 | 2024 | 2380 | 0.870 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 8 | 2017 | 225 | 0.860 |
Why?
|
| Immunoconjugates | 4 | 2024 | 949 | 0.860 |
Why?
|
| T-Lymphocytes | 21 | 2023 | 10181 | 0.840 |
Why?
|
| Granulocytes | 4 | 2023 | 551 | 0.840 |
Why?
|
| Dioxygenases | 1 | 2024 | 335 | 0.790 |
Why?
|
| Osteogenesis | 8 | 2020 | 1271 | 0.760 |
Why?
|
| Malate Dehydrogenase | 1 | 2021 | 40 | 0.750 |
Why?
|
| Colony-Forming Units Assay | 14 | 2012 | 351 | 0.740 |
Why?
|
| Multiprotein Complexes | 4 | 2017 | 1120 | 0.740 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 20 | 0.740 |
Why?
|
| Signal Transduction | 38 | 2024 | 23376 | 0.730 |
Why?
|
| Cell Proliferation | 22 | 2022 | 10446 | 0.720 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2020 | 87 | 0.710 |
Why?
|
| Myelodysplastic Syndromes | 4 | 2023 | 1394 | 0.710 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2023 | 114 | 0.710 |
Why?
|
| Cells, Cultured | 50 | 2022 | 18957 | 0.710 |
Why?
|
| Fumarates | 1 | 2021 | 131 | 0.710 |
Why?
|
| Antigens, Differentiation | 4 | 2015 | 911 | 0.710 |
Why?
|
| Leukemia, Myeloid | 3 | 2013 | 695 | 0.710 |
Why?
|
| Fracture Healing | 2 | 2014 | 438 | 0.700 |
Why?
|
| Phenylenediamines | 1 | 2020 | 86 | 0.700 |
Why?
|
| Homeostasis | 12 | 2019 | 3306 | 0.700 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2017 | 88 | 0.690 |
Why?
|
| Stress, Physiological | 6 | 2019 | 1398 | 0.680 |
Why?
|
| Humans | 268 | 2024 | 760621 | 0.680 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 1035 | 0.670 |
Why?
|
| Receptors, Purinergic P2Y | 4 | 2014 | 24 | 0.660 |
Why?
|
| Mice, Knockout | 39 | 2024 | 14372 | 0.660 |
Why?
|
| Cyclins | 5 | 2014 | 593 | 0.650 |
Why?
|
| Carbon | 2 | 2022 | 669 | 0.640 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2019 | 174 | 0.640 |
Why?
|
| AIDS-Related Opportunistic Infections | 8 | 2007 | 662 | 0.630 |
Why?
|
| Carbolines | 1 | 2020 | 288 | 0.620 |
Why?
|
| Transplantation Conditioning | 4 | 2024 | 1588 | 0.620 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2017 | 2058 | 0.620 |
Why?
|
| Flow Cytometry | 23 | 2024 | 5870 | 0.600 |
Why?
|
| Endothelial Cells | 18 | 2022 | 3539 | 0.600 |
Why?
|
| Blood Vessels | 8 | 2016 | 1112 | 0.590 |
Why?
|
| Myeloproliferative Disorders | 5 | 2018 | 609 | 0.580 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 8 | 2008 | 358 | 0.580 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2024 | 4490 | 0.580 |
Why?
|
| Homeodomain Proteins | 9 | 2020 | 2414 | 0.580 |
Why?
|
| Mice, Inbred NOD | 12 | 2021 | 1837 | 0.560 |
Why?
|
| Tissue Scaffolds | 4 | 2019 | 928 | 0.560 |
Why?
|
| HIV-1 | 24 | 2007 | 6849 | 0.560 |
Why?
|
| Receptors, CXCR4 | 7 | 2016 | 728 | 0.550 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2016 | 27 | 0.550 |
Why?
|
| Mice, SCID | 23 | 2021 | 2627 | 0.550 |
Why?
|
| Cell Communication | 5 | 2020 | 1653 | 0.540 |
Why?
|
| Lactic Acid | 1 | 2022 | 1134 | 0.540 |
Why?
|
| Mesoderm | 3 | 2016 | 672 | 0.540 |
Why?
|
| Tissue Preservation | 1 | 2016 | 174 | 0.530 |
Why?
|
| Stem Cell Research | 2 | 2019 | 37 | 0.530 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 1091 | 0.530 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2022 | 2828 | 0.520 |
Why?
|
| DNA-Binding Proteins | 10 | 2024 | 9585 | 0.520 |
Why?
|
| Regeneration | 6 | 2019 | 1506 | 0.520 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2005 | 1375 | 0.520 |
Why?
|
| Multiple Myeloma | 12 | 2021 | 5130 | 0.520 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 13 | 2020 | 886 | 0.510 |
Why?
|
| Mice, Transgenic | 23 | 2020 | 9530 | 0.500 |
Why?
|
| Osteocytes | 2 | 2014 | 192 | 0.500 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2019 | 1810 | 0.500 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2016 | 2802 | 0.500 |
Why?
|
| Bone Marrow Purging | 3 | 2008 | 108 | 0.490 |
Why?
|
| Culture Media | 1 | 2016 | 900 | 0.480 |
Why?
|
| Macrophages | 13 | 2023 | 5745 | 0.480 |
Why?
|
| Epitopes | 5 | 2016 | 2503 | 0.480 |
Why?
|
| DNA Damage | 4 | 2023 | 2442 | 0.470 |
Why?
|
| Hematologic Diseases | 5 | 2000 | 496 | 0.470 |
Why?
|
| Hemolymph | 1 | 2013 | 27 | 0.460 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2013 | 28 | 0.460 |
Why?
|
| Neoplasm Proteins | 5 | 2020 | 3610 | 0.460 |
Why?
|
| Apoptosis | 16 | 2021 | 9501 | 0.450 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3758 | 0.450 |
Why?
|
| Herpesvirus 4, Human | 9 | 2007 | 1075 | 0.450 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 3 | 2012 | 195 | 0.450 |
Why?
|
| Gene Targeting | 2 | 2017 | 839 | 0.450 |
Why?
|
| Spleen | 6 | 2013 | 2298 | 0.440 |
Why?
|
| Chemokine CXCL12 | 13 | 2016 | 454 | 0.440 |
Why?
|
| HIV Infections | 25 | 2013 | 17165 | 0.440 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 224 | 0.440 |
Why?
|
| Antigens, CD | 14 | 2017 | 4000 | 0.430 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 167 | 0.430 |
Why?
|
| Chemokines, CXC | 7 | 2007 | 421 | 0.420 |
Why?
|
| Gene Deletion | 5 | 2016 | 2668 | 0.420 |
Why?
|
| Receptors, Notch | 6 | 2015 | 743 | 0.420 |
Why?
|
| Neoplasms | 14 | 2020 | 22072 | 0.420 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2013 | 183 | 0.420 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2002 | 626 | 0.410 |
Why?
|
| Sequence Analysis, RNA | 4 | 2022 | 2005 | 0.410 |
Why?
|
| beta Catenin | 3 | 2014 | 1043 | 0.410 |
Why?
|
| Microscopy, Fluorescence | 4 | 2022 | 2651 | 0.410 |
Why?
|
| Membrane Proteins | 12 | 2016 | 7850 | 0.410 |
Why?
|
| Osteocalcin | 4 | 2019 | 274 | 0.400 |
Why?
|
| Hair Follicle | 1 | 2014 | 210 | 0.400 |
Why?
|
| Gene Expression Regulation | 17 | 2021 | 11903 | 0.400 |
Why?
|
| Mice, Inbred Strains | 9 | 2016 | 1763 | 0.400 |
Why?
|
| Specimen Handling | 1 | 2016 | 707 | 0.400 |
Why?
|
| Transcription Factors | 16 | 2021 | 12103 | 0.390 |
Why?
|
| Transduction, Genetic | 7 | 2009 | 897 | 0.390 |
Why?
|
| Interleukin-3 | 9 | 2012 | 425 | 0.390 |
Why?
|
| Immunophenotyping | 14 | 2020 | 1871 | 0.390 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 877 | 0.390 |
Why?
|
| Receptors, CCR5 | 3 | 2011 | 488 | 0.380 |
Why?
|
| Parathyroid Hormone | 6 | 2013 | 1797 | 0.380 |
Why?
|
| Mitochondria | 5 | 2021 | 3600 | 0.380 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 491 | 0.380 |
Why?
|
| T-Lymphocytes, Cytotoxic | 8 | 2013 | 1765 | 0.370 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2250 | 0.370 |
Why?
|
| Forkhead Transcription Factors | 6 | 2020 | 1612 | 0.370 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2013 | 1652 | 0.370 |
Why?
|
| Epigenomics | 1 | 2016 | 936 | 0.370 |
Why?
|
| Disease Progression | 8 | 2023 | 13502 | 0.370 |
Why?
|
| Hematopoietic System | 2 | 2008 | 109 | 0.360 |
Why?
|
| Nerve Fibers | 1 | 2014 | 708 | 0.360 |
Why?
|
| Graft vs Host Disease | 2 | 2024 | 3025 | 0.360 |
Why?
|
| Fetal Blood | 8 | 2013 | 1343 | 0.360 |
Why?
|
| Hair | 1 | 2014 | 497 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 2873 | 0.360 |
Why?
|
| Chemotaxis | 3 | 2006 | 598 | 0.350 |
Why?
|
| Glycolysis | 1 | 2014 | 828 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2021 | 2895 | 0.350 |
Why?
|
| Exons | 1 | 2016 | 2388 | 0.350 |
Why?
|
| B-Lymphocytes | 7 | 2022 | 4742 | 0.350 |
Why?
|
| Tumor Cells, Cultured | 18 | 2022 | 6131 | 0.350 |
Why?
|
| Cell Count | 10 | 2022 | 1835 | 0.350 |
Why?
|
| Cell Division | 17 | 2010 | 4463 | 0.340 |
Why?
|
| Biomimetics | 1 | 2011 | 173 | 0.340 |
Why?
|
| Cytokines | 12 | 2023 | 7343 | 0.340 |
Why?
|
| Organ Specificity | 6 | 2007 | 1955 | 0.340 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3726 | 0.330 |
Why?
|
| Gene Expression Profiling | 13 | 2024 | 9411 | 0.330 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2001 | 663 | 0.320 |
Why?
|
| Leukopoiesis | 2 | 1999 | 55 | 0.320 |
Why?
|
| Pluripotent Stem Cells | 2 | 2008 | 792 | 0.320 |
Why?
|
| Antineoplastic Agents | 15 | 2021 | 13630 | 0.320 |
Why?
|
| Gene Expression Regulation, Leukemic | 5 | 2021 | 646 | 0.320 |
Why?
|
| Calcium-Binding Proteins | 5 | 2019 | 1067 | 0.320 |
Why?
|
| Cell Cycle Proteins | 8 | 2014 | 3446 | 0.310 |
Why?
|
| Cell Line, Tumor | 19 | 2021 | 16939 | 0.310 |
Why?
|
| Paclitaxel | 4 | 2002 | 1736 | 0.310 |
Why?
|
| Endoribonucleases | 1 | 2010 | 229 | 0.310 |
Why?
|
| Receptors, Cell Surface | 6 | 2010 | 2825 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 2448 | 0.310 |
Why?
|
| Genes, Developmental | 1 | 2008 | 38 | 0.310 |
Why?
|
| Electrochemotherapy | 1 | 2008 | 7 | 0.310 |
Why?
|
| Virus Replication | 6 | 2007 | 2432 | 0.310 |
Why?
|
| Mutation | 9 | 2024 | 29932 | 0.310 |
Why?
|
| Cell Line | 24 | 2021 | 15620 | 0.300 |
Why?
|
| Mice, Congenic | 2 | 2020 | 97 | 0.300 |
Why?
|
| Megakaryocytes | 6 | 2016 | 565 | 0.300 |
Why?
|
| Immune System | 2 | 2003 | 798 | 0.300 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2013 | 151 | 0.300 |
Why?
|
| MicroRNAs | 5 | 2013 | 3790 | 0.300 |
Why?
|
| Receptors, Calcitriol | 1 | 2010 | 359 | 0.300 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 18137 | 0.300 |
Why?
|
| Wnt Proteins | 2 | 2011 | 719 | 0.300 |
Why?
|
| Adipocytes | 4 | 2016 | 1179 | 0.300 |
Why?
|
| Multipotent Stem Cells | 3 | 2021 | 200 | 0.290 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 383 | 0.290 |
Why?
|
| Neurofibromin 2 | 1 | 2008 | 270 | 0.290 |
Why?
|
| Immunotoxins | 2 | 2016 | 175 | 0.280 |
Why?
|
| Immunity | 2 | 2019 | 998 | 0.280 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 3075 | 0.280 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2005 | 318 | 0.280 |
Why?
|
| Hematopoietic Cell Growth Factors | 6 | 1999 | 98 | 0.270 |
Why?
|
| Osteoclasts | 4 | 2018 | 711 | 0.270 |
Why?
|
| Colony-Stimulating Factors | 3 | 1992 | 218 | 0.270 |
Why?
|
| NIH 3T3 Cells | 2 | 2021 | 670 | 0.270 |
Why?
|
| Zidovudine | 5 | 1996 | 624 | 0.270 |
Why?
|
| Anti-HIV Agents | 8 | 2012 | 4491 | 0.270 |
Why?
|
| Cell Survival | 12 | 2019 | 5797 | 0.260 |
Why?
|
| Transplantation, Homologous | 7 | 2024 | 4810 | 0.260 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2013 | 305 | 0.260 |
Why?
|
| Caspase 3 | 1 | 2008 | 731 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2012 | 1115 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2019 | 4573 | 0.260 |
Why?
|
| Ribonuclease, Pancreatic | 2 | 2016 | 149 | 0.260 |
Why?
|
| Carrier Proteins | 6 | 2014 | 4938 | 0.260 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1741 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 2 | 2016 | 2803 | 0.250 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1262 | 0.250 |
Why?
|
| Receptor, EphB4 | 2 | 2003 | 39 | 0.250 |
Why?
|
| RNA Interference | 5 | 2021 | 2846 | 0.240 |
Why?
|
| Bone Regeneration | 1 | 2008 | 432 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2021 | 544 | 0.240 |
Why?
|
| Myelopoiesis | 3 | 2015 | 134 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2023 | 4550 | 0.240 |
Why?
|
| Protease Inhibitors | 2 | 2008 | 755 | 0.240 |
Why?
|
| Boronic Acids | 2 | 2009 | 914 | 0.240 |
Why?
|
| Genetic Vectors | 8 | 2005 | 3380 | 0.240 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 1710 | 0.240 |
Why?
|
| Proteome | 1 | 2014 | 1855 | 0.230 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 315 | 0.230 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2008 | 11712 | 0.230 |
Why?
|
| Tissue Engineering | 5 | 2015 | 1870 | 0.230 |
Why?
|
| RNA, Small Interfering | 7 | 2021 | 3442 | 0.230 |
Why?
|
| HIV | 6 | 2013 | 1579 | 0.230 |
Why?
|
| Ribonuclease III | 3 | 2010 | 279 | 0.230 |
Why?
|
| Embryo, Mammalian | 3 | 2006 | 1674 | 0.230 |
Why?
|
| RNA-Binding Proteins | 3 | 2024 | 1894 | 0.230 |
Why?
|
| Adult | 54 | 2023 | 219994 | 0.230 |
Why?
|
| Transplantation, Heterologous | 9 | 2019 | 2379 | 0.230 |
Why?
|
| Receptors, Leptin | 3 | 2020 | 350 | 0.230 |
Why?
|
| Graft Survival | 5 | 2013 | 3794 | 0.230 |
Why?
|
| Antiretroviral Therapy, Highly Active | 9 | 2012 | 1894 | 0.230 |
Why?
|
| Anemia | 5 | 2014 | 1511 | 0.220 |
Why?
|
| Aggrecans | 1 | 2023 | 87 | 0.220 |
Why?
|
| Erythropoietin | 6 | 2008 | 720 | 0.220 |
Why?
|
| RNA, Messenger | 20 | 2020 | 12766 | 0.220 |
Why?
|
| Lysine | 1 | 2008 | 1001 | 0.220 |
Why?
|
| Gene Expression | 10 | 2020 | 7588 | 0.220 |
Why?
|
| Receptor, Notch1 | 4 | 2018 | 495 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 698 | 0.220 |
Why?
|
| Neutropenia | 8 | 2001 | 884 | 0.220 |
Why?
|
| Doxorubicin | 6 | 2020 | 2209 | 0.220 |
Why?
|
| Down-Regulation | 6 | 2021 | 2913 | 0.220 |
Why?
|
| Transplantation, Autologous | 4 | 2019 | 2116 | 0.210 |
Why?
|
| Collagen Type II | 1 | 2023 | 148 | 0.210 |
Why?
|
| Up-Regulation | 8 | 2021 | 4122 | 0.210 |
Why?
|
| Base Sequence | 22 | 2014 | 12446 | 0.210 |
Why?
|
| Electroporation | 1 | 2004 | 255 | 0.210 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 691 | 0.210 |
Why?
|
| Gene Products, tat | 2 | 2000 | 111 | 0.210 |
Why?
|
| Pyrazines | 2 | 2009 | 1199 | 0.210 |
Why?
|
| Adoptive Transfer | 4 | 2019 | 822 | 0.210 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 381 | 0.210 |
Why?
|
| Inflammation | 7 | 2020 | 10756 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 829 | 0.210 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2016 | 1055 | 0.210 |
Why?
|
| ADP-ribosyl Cyclase | 4 | 2003 | 38 | 0.210 |
Why?
|
| Aging | 5 | 2017 | 8651 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 2019 | 727 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2021 | 5253 | 0.210 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2002 | 656 | 0.200 |
Why?
|
| Molecular Sequence Data | 20 | 2014 | 17624 | 0.200 |
Why?
|
| Transplantation | 1 | 2004 | 218 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 15 | 2005 | 6068 | 0.200 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2020 | 226 | 0.200 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2020 | 301 | 0.200 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2013 | 101 | 0.200 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2021 | 33 | 0.200 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 80 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 6 | 2020 | 9185 | 0.200 |
Why?
|
| Male | 75 | 2023 | 359744 | 0.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2013 | 4353 | 0.190 |
Why?
|
| Cell Transplantation | 2 | 2007 | 472 | 0.190 |
Why?
|
| Chemokine CCL20 | 1 | 2021 | 63 | 0.190 |
Why?
|
| Fanconi Anemia | 1 | 2024 | 324 | 0.190 |
Why?
|
| Membrane Glycoproteins | 7 | 2016 | 3707 | 0.190 |
Why?
|
| Transcription, Genetic | 9 | 2016 | 7593 | 0.190 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2020 | 1596 | 0.190 |
Why?
|
| Thymidine | 2 | 2021 | 299 | 0.190 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2022 | 126 | 0.190 |
Why?
|
| Receptors, CCR6 | 1 | 2021 | 73 | 0.190 |
Why?
|
| Alginates | 2 | 2019 | 248 | 0.190 |
Why?
|
| Growth Substances | 2 | 1996 | 768 | 0.190 |
Why?
|
| HIV Protease Inhibitors | 3 | 2002 | 432 | 0.190 |
Why?
|
| HMGA1a Protein | 1 | 2021 | 61 | 0.190 |
Why?
|
| Female | 72 | 2021 | 391270 | 0.180 |
Why?
|
| HLA-A Antigens | 1 | 2001 | 225 | 0.180 |
Why?
|
| Models, Animal | 4 | 2015 | 2117 | 0.180 |
Why?
|
| Interleukin-4 | 2 | 2002 | 1130 | 0.180 |
Why?
|
| Pyrophosphatases | 1 | 2021 | 139 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2023 | 2919 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2014 | 1513 | 0.180 |
Why?
|
| Chondrogenesis | 2 | 2020 | 239 | 0.180 |
Why?
|
| Oleic Acid | 1 | 2020 | 92 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 127 | 0.180 |
Why?
|
| Antimetabolites | 2 | 2000 | 128 | 0.180 |
Why?
|
| Proteoglycans | 1 | 2023 | 801 | 0.180 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 131 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2014 | 4373 | 0.180 |
Why?
|
| Research | 1 | 2008 | 1974 | 0.170 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 230 | 0.170 |
Why?
|
| Acetylcholine | 1 | 2022 | 629 | 0.170 |
Why?
|
| Protein Binding | 6 | 2021 | 9335 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 8515 | 0.170 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 48 | 0.170 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 271 | 0.170 |
Why?
|
| Neoplasms, Experimental | 3 | 2017 | 1229 | 0.170 |
Why?
|
| Aldehydes | 1 | 2020 | 170 | 0.170 |
Why?
|
| DNA Primers | 8 | 2004 | 2819 | 0.170 |
Why?
|
| Oxidation-Reduction | 3 | 2020 | 2222 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2005 | 608 | 0.170 |
Why?
|
| Dimerization | 1 | 2021 | 891 | 0.170 |
Why?
|
| Cytarabine | 2 | 2020 | 696 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2009 | 319 | 0.160 |
Why?
|
| Gliosis | 1 | 2020 | 244 | 0.160 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 145 | 0.160 |
Why?
|
| Ribosomes | 1 | 2022 | 501 | 0.160 |
Why?
|
| Periosteum | 1 | 2019 | 138 | 0.160 |
Why?
|
| Septins | 1 | 2019 | 49 | 0.160 |
Why?
|
| Glucans | 1 | 1999 | 68 | 0.160 |
Why?
|
| Lentivirus | 3 | 2009 | 506 | 0.160 |
Why?
|
| Artificial Organs | 1 | 2000 | 149 | 0.160 |
Why?
|
| Adipose Tissue | 3 | 2019 | 3301 | 0.160 |
Why?
|
| Ganciclovir | 2 | 1996 | 252 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2019 | 68 | 0.160 |
Why?
|
| Nuclear Proteins | 9 | 2018 | 5791 | 0.160 |
Why?
|
| Tumor Virus Infections | 1 | 2001 | 438 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1135 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2021 | 363 | 0.160 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2018 | 35 | 0.160 |
Why?
|
| Societies, Scientific | 1 | 2019 | 221 | 0.160 |
Why?
|
| Osteolysis | 2 | 2011 | 274 | 0.160 |
Why?
|
| Virus Latency | 2 | 2003 | 362 | 0.160 |
Why?
|
| Receptors, CCR2 | 2 | 2015 | 215 | 0.160 |
Why?
|
| Skin Neoplasms | 5 | 2001 | 5799 | 0.160 |
Why?
|
| Cyclophosphamide | 5 | 2008 | 2221 | 0.150 |
Why?
|
| Neoplasm Transplantation | 7 | 2018 | 2014 | 0.150 |
Why?
|
| Recombinant Proteins | 13 | 2011 | 6538 | 0.150 |
Why?
|
| Liver | 4 | 2018 | 7509 | 0.150 |
Why?
|
| Clone Cells | 4 | 2019 | 1660 | 0.150 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 161 | 0.150 |
Why?
|
| Stem Cell Factor | 6 | 2012 | 196 | 0.150 |
Why?
|
| beta-Glucans | 1 | 1999 | 121 | 0.150 |
Why?
|
| Chimerism | 1 | 2019 | 155 | 0.150 |
Why?
|
| Atlases as Topic | 1 | 2019 | 241 | 0.150 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 126 | 0.150 |
Why?
|
| Models, Biological | 7 | 2021 | 9467 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2024 | 3218 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 342 | 0.150 |
Why?
|
| Histones | 1 | 2008 | 2583 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2020 | 593 | 0.150 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2012 | 685 | 0.150 |
Why?
|
| Proline | 2 | 2016 | 457 | 0.150 |
Why?
|
| Leukopenia | 2 | 1995 | 211 | 0.140 |
Why?
|
| Microglia | 2 | 2023 | 1351 | 0.140 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2002 | 590 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 296 | 0.140 |
Why?
|
| HIV Core Protein p24 | 5 | 2002 | 245 | 0.140 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2018 | 132 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 6216 | 0.140 |
Why?
|
| Interferon-alpha | 5 | 2007 | 918 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2502 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1131 | 0.140 |
Why?
|
| HIV Seropositivity | 4 | 2005 | 955 | 0.140 |
Why?
|
| Vincristine | 5 | 2005 | 1039 | 0.140 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2016 | 75 | 0.140 |
Why?
|
| Cinnamates | 1 | 1996 | 59 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 5 | 2007 | 2640 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 2536 | 0.140 |
Why?
|
| Atrophy | 2 | 2019 | 1627 | 0.140 |
Why?
|
| Immunogenetic Phenomena | 1 | 2016 | 23 | 0.140 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2002 | 618 | 0.140 |
Why?
|
| Genetic Enhancement | 1 | 2016 | 17 | 0.140 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2016 | 72 | 0.140 |
Why?
|
| Fluorescence | 2 | 2016 | 751 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1697 | 0.140 |
Why?
|
| GATA2 Transcription Factor | 2 | 2008 | 158 | 0.140 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2016 | 20 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2014 | 10827 | 0.140 |
Why?
|
| Blotting, Western | 7 | 2012 | 5039 | 0.140 |
Why?
|
| Skull | 3 | 2010 | 815 | 0.130 |
Why?
|
| Protons | 1 | 2022 | 1114 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2022 | 1152 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 2571 | 0.130 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 282 | 0.130 |
Why?
|
| Staining and Labeling | 3 | 2013 | 1089 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 3 | 2011 | 263 | 0.130 |
Why?
|
| Viral Proteins | 3 | 2007 | 1802 | 0.130 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2016 | 66 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 995 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 366 | 0.130 |
Why?
|
| Chromatin | 2 | 2021 | 2938 | 0.130 |
Why?
|
| Chorionic Gonadotropin | 1 | 1998 | 457 | 0.130 |
Why?
|
| Antigen Presentation | 2 | 2004 | 1254 | 0.130 |
Why?
|
| RNA, Viral | 7 | 2003 | 2838 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 2 | 2001 | 1959 | 0.130 |
Why?
|
| Chemokine CCL3 | 2 | 2016 | 84 | 0.130 |
Why?
|
| Binding, Competitive | 2 | 2014 | 1142 | 0.130 |
Why?
|
| Australia | 1 | 2019 | 1289 | 0.130 |
Why?
|
| Isoenzymes | 3 | 2014 | 1690 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 484 | 0.130 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2017 | 200 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2016 | 224 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 1245 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 858 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 2057 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1077 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2019 | 547 | 0.120 |
Why?
|
| Awards and Prizes | 1 | 2019 | 359 | 0.120 |
Why?
|
| Fas Ligand Protein | 2 | 2014 | 215 | 0.120 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 191 | 0.120 |
Why?
|
| Integrin beta3 | 2 | 2013 | 121 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2014 | 3775 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 608 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 393 | 0.120 |
Why?
|
| Erythropoiesis | 2 | 2016 | 682 | 0.120 |
Why?
|
| Coculture Techniques | 5 | 2003 | 1342 | 0.120 |
Why?
|
| Antigens, Viral | 4 | 2007 | 980 | 0.120 |
Why?
|
| Fetus | 5 | 2005 | 1859 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2006 | 3486 | 0.120 |
Why?
|
| Calcium | 4 | 2001 | 5725 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 475 | 0.120 |
Why?
|
| Interleukin-18 | 1 | 2016 | 251 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2015 | 801 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 1995 | 258 | 0.120 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 197 | 0.120 |
Why?
|
| DNA, Complementary | 7 | 1999 | 1991 | 0.120 |
Why?
|
| Protein Kinase C-alpha | 1 | 2014 | 113 | 0.120 |
Why?
|
| Burkitt Lymphoma | 1 | 1996 | 333 | 0.120 |
Why?
|
| Genes, src | 1 | 1994 | 51 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2010 | 3426 | 0.120 |
Why?
|
| Time Factors | 12 | 2019 | 40165 | 0.120 |
Why?
|
| Organoids | 1 | 2000 | 729 | 0.120 |
Why?
|
| Actins | 2 | 2019 | 2049 | 0.110 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Proteinuria | 1 | 2016 | 594 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 1056 | 0.110 |
Why?
|
| Genes, abl | 1 | 2013 | 69 | 0.110 |
Why?
|
| SOXC Transcription Factors | 1 | 2013 | 41 | 0.110 |
Why?
|
| Neutrophils | 3 | 2017 | 3767 | 0.110 |
Why?
|
| Uridine Diphosphate Glucose | 1 | 2013 | 22 | 0.110 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 1204 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2013 | 286 | 0.110 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2016 | 325 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 384 | 0.110 |
Why?
|
| Daunorubicin | 3 | 1998 | 156 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 412 | 0.110 |
Why?
|
| 3T3 Cells | 4 | 2001 | 1085 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1407 | 0.110 |
Why?
|
| Brain | 3 | 2017 | 26951 | 0.110 |
Why?
|
| Photochemistry | 1 | 2013 | 239 | 0.110 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1902 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2014 | 62 | 0.110 |
Why?
|
| HIV-2 | 2 | 1990 | 156 | 0.110 |
Why?
|
| Amino Acid Sequence | 11 | 2016 | 13451 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 1693 | 0.100 |
Why?
|
| RNA | 4 | 2018 | 2722 | 0.100 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 190 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 4 | 2013 | 498 | 0.100 |
Why?
|
| Dependovirus | 1 | 1997 | 709 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 1995 | 1613 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 444 | 0.100 |
Why?
|
| Sirtuin 3 | 1 | 2013 | 68 | 0.100 |
Why?
|
| Fatty Acids | 2 | 2020 | 1804 | 0.100 |
Why?
|
| Antiviral Agents | 4 | 2001 | 3061 | 0.100 |
Why?
|
| Ligands | 5 | 2014 | 3276 | 0.100 |
Why?
|
| Blood Cell Count | 3 | 2000 | 397 | 0.100 |
Why?
|
| Intracellular Fluid | 3 | 2001 | 201 | 0.100 |
Why?
|
| Blotting, Southern | 3 | 2001 | 777 | 0.100 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 1046 | 0.100 |
Why?
|
| Rectal Neoplasms | 3 | 2006 | 1152 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2000 | 916 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2192 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2013 | 490 | 0.100 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 21 | 0.100 |
Why?
|
| Bone Marrow Diseases | 1 | 1994 | 232 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2020 | 1817 | 0.100 |
Why?
|
| Orthomyxoviridae | 1 | 2013 | 148 | 0.100 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 2532 | 0.100 |
Why?
|
| Busulfan | 2 | 2014 | 258 | 0.100 |
Why?
|
| Immunohistochemistry | 10 | 2019 | 11071 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 1737 | 0.100 |
Why?
|
| Phosphorylation | 5 | 2019 | 8313 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 247 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 3 | 2015 | 1336 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2013 | 3682 | 0.100 |
Why?
|
| Cyclin D1 | 2 | 2014 | 451 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2016 | 4264 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 1999 | 981 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 129 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3106 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2014 | 1649 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 485 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 717 | 0.090 |
Why?
|
| NAD+ Nucleosidase | 2 | 2001 | 43 | 0.090 |
Why?
|
| Cattle | 1 | 2016 | 3847 | 0.090 |
Why?
|
| Nerve Regeneration | 2 | 2009 | 791 | 0.090 |
Why?
|
| Coloring Agents | 1 | 2013 | 562 | 0.090 |
Why?
|
| Amino Acids | 1 | 2017 | 1714 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 734 | 0.090 |
Why?
|
| Point Mutation | 1 | 2016 | 1594 | 0.090 |
Why?
|
| Blood Cells | 2 | 2003 | 305 | 0.090 |
Why?
|
| Microfluidics | 2 | 2018 | 652 | 0.090 |
Why?
|
| Glycoproteins | 3 | 2012 | 2208 | 0.090 |
Why?
|
| Biological Therapy | 1 | 2012 | 139 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 944 | 0.090 |
Why?
|
| Multigene Family | 1 | 1994 | 1077 | 0.090 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 701 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2016 | 1928 | 0.090 |
Why?
|
| Moloney murine sarcoma virus | 1 | 1990 | 4 | 0.090 |
Why?
|
| Mink Cell Focus-Inducing Viruses | 1 | 1990 | 3 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 170 | 0.090 |
Why?
|
| Sarcoma Viruses, Murine | 1 | 1990 | 17 | 0.090 |
Why?
|
| Dipeptides | 2 | 2004 | 409 | 0.090 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2010 | 71 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 3584 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2016 | 5434 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1296 | 0.090 |
Why?
|
| Oncogenes | 2 | 2013 | 1220 | 0.090 |
Why?
|
| Antineoplastic Protocols | 1 | 2010 | 50 | 0.090 |
Why?
|
| Bleomycin | 3 | 2001 | 495 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2006 | 2049 | 0.090 |
Why?
|
| Dinoprostone | 1 | 2013 | 598 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1869 | 0.090 |
Why?
|
| HL-60 Cells | 3 | 2019 | 363 | 0.090 |
Why?
|
| Endothelium, Vascular | 3 | 2007 | 4433 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2003 | 412 | 0.090 |
Why?
|
| Proviruses | 2 | 1999 | 313 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2017 | 1547 | 0.090 |
Why?
|
| Sarcoma, Myeloid | 1 | 2010 | 51 | 0.090 |
Why?
|
| Leukemia Virus, Murine | 1 | 1990 | 94 | 0.090 |
Why?
|
| Pyrimidines | 3 | 2019 | 3016 | 0.080 |
Why?
|
| Drug Evaluation | 4 | 1992 | 641 | 0.080 |
Why?
|
| Bioreactors | 1 | 2011 | 244 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 1998 | 675 | 0.080 |
Why?
|
| Leukocytosis | 2 | 2021 | 251 | 0.080 |
Why?
|
| Kinetics | 4 | 2009 | 6377 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 11345 | 0.080 |
Why?
|
| K562 Cells | 3 | 2018 | 640 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2013 | 824 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 1995 | 1411 | 0.080 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 1 | 2008 | 21 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4902 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2012 | 504 | 0.080 |
Why?
|
| Flavones | 1 | 2009 | 68 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2013 | 1008 | 0.080 |
Why?
|
| Contact Inhibition | 1 | 2008 | 46 | 0.080 |
Why?
|
| Capillaries | 2 | 2009 | 744 | 0.080 |
Why?
|
| Interferon Type I | 2 | 1991 | 559 | 0.080 |
Why?
|
| Osteopontin | 2 | 2013 | 302 | 0.080 |
Why?
|
| Activins | 1 | 2010 | 211 | 0.080 |
Why?
|
| Knowledge | 1 | 2010 | 176 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 184 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3527 | 0.080 |
Why?
|
| Exosomes | 1 | 2013 | 424 | 0.080 |
Why?
|
| Tretinoin | 2 | 2002 | 519 | 0.080 |
Why?
|
| Cell Death | 3 | 2019 | 1672 | 0.080 |
Why?
|
| Immunity, Cellular | 4 | 2007 | 1557 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 1999 | 2753 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2008 | 459 | 0.080 |
Why?
|
| Transfection | 5 | 2003 | 5781 | 0.080 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 956 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2014 | 1112 | 0.080 |
Why?
|
| Benzylamines | 3 | 2017 | 248 | 0.080 |
Why?
|
| Heart Transplantation | 2 | 1998 | 3224 | 0.070 |
Why?
|
| raf Kinases | 1 | 2008 | 118 | 0.070 |
Why?
|
| Blotting, Northern | 3 | 2001 | 1543 | 0.070 |
Why?
|
| Peptides | 3 | 2009 | 4354 | 0.070 |
Why?
|
| Erythroid Precursor Cells | 2 | 2002 | 211 | 0.070 |
Why?
|
| Parabiosis | 1 | 2007 | 64 | 0.070 |
Why?
|
| Treatment Outcome | 11 | 2021 | 65017 | 0.070 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2007 | 33 | 0.070 |
Why?
|
| Heterocyclic Compounds | 3 | 2017 | 247 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2008 | 3442 | 0.070 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 2138 | 0.070 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2008 | 82 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 186 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 522 | 0.070 |
Why?
|
| Wound Healing | 3 | 2020 | 2788 | 0.070 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2012 | 305 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2011 | 580 | 0.070 |
Why?
|
| Survival Rate | 7 | 2021 | 12808 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2016 | 2488 | 0.070 |
Why?
|
| Remission Induction | 6 | 2004 | 2392 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2021 | 3517 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2009 | 250 | 0.070 |
Why?
|
| Heparin | 1 | 2014 | 1652 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2008 | 4357 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2008 | 3604 | 0.070 |
Why?
|
| Cell Adhesion | 6 | 2021 | 3094 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2008 | 256 | 0.070 |
Why?
|
| Kidney | 4 | 2022 | 7064 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1921 | 0.070 |
Why?
|
| Erythroid Cells | 1 | 2008 | 235 | 0.070 |
Why?
|
| Ceramides | 1 | 2008 | 201 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 2013 | 763 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2007 | 224 | 0.070 |
Why?
|
| Immunologic Factors | 2 | 1993 | 1588 | 0.070 |
Why?
|
| Cholera Toxin | 1 | 2009 | 559 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9276 | 0.070 |
Why?
|
| Proteins | 5 | 2010 | 6029 | 0.070 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2006 | 77 | 0.070 |
Why?
|
| Viremia | 3 | 2007 | 707 | 0.070 |
Why?
|
| Heterozygote | 2 | 2005 | 2798 | 0.070 |
Why?
|
| Interleukin-6 | 6 | 2021 | 3215 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2008 | 6828 | 0.070 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2326 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2012 | 929 | 0.070 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2005 | 49 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 6315 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 841 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4312 | 0.060 |
Why?
|
| Gene Products, gag | 2 | 2000 | 312 | 0.060 |
Why?
|
| Chondrocytes | 3 | 2020 | 791 | 0.060 |
Why?
|
| Extracellular Matrix | 3 | 2012 | 1726 | 0.060 |
Why?
|
| Fluorouracil | 3 | 2005 | 1631 | 0.060 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 367 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1139 | 0.060 |
Why?
|
| International Cooperation | 1 | 2012 | 1433 | 0.060 |
Why?
|
| Methylation | 1 | 2008 | 1082 | 0.060 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 290 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 352 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2010 | 3602 | 0.060 |
Why?
|
| Thrombocytopenia | 4 | 2014 | 1174 | 0.060 |
Why?
|
| Fibroblasts | 3 | 1995 | 4090 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4024 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2012 | 941 | 0.060 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 193 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2008 | 3484 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 18416 | 0.060 |
Why?
|
| Angiopoietin-1 | 1 | 2005 | 122 | 0.060 |
Why?
|
| Lymphatic Diseases | 1 | 2006 | 319 | 0.060 |
Why?
|
| Translocation, Genetic | 3 | 2019 | 1388 | 0.060 |
Why?
|
| Combined Modality Therapy | 5 | 2005 | 8552 | 0.060 |
Why?
|
| Interleukin-2 | 3 | 1997 | 1889 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2006 | 277 | 0.060 |
Why?
|
| Viral Load | 7 | 2007 | 3322 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2005 | 241 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2418 | 0.060 |
Why?
|
| Lymphoma | 2 | 2008 | 1898 | 0.060 |
Why?
|
| RANK Ligand | 1 | 2006 | 318 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1972 | 0.060 |
Why?
|
| Leukapheresis | 1 | 2004 | 134 | 0.060 |
Why?
|
| Drug Administration Schedule | 5 | 2005 | 4899 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 3 | 2011 | 4407 | 0.060 |
Why?
|
| DNA, Viral | 7 | 2005 | 2194 | 0.060 |
Why?
|
| Skin | 2 | 2013 | 4466 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 58 | 0.060 |
Why?
|
| Middle Aged | 29 | 2019 | 220352 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 5785 | 0.060 |
Why?
|
| Survival Analysis | 7 | 2016 | 10182 | 0.060 |
Why?
|
| Quantum Dots | 1 | 2005 | 168 | 0.060 |
Why?
|
| DNA, Antisense | 1 | 2003 | 44 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1999 | 3735 | 0.060 |
Why?
|
| CpG Islands | 1 | 2008 | 1221 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 1039 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2005 | 266 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2007 | 2569 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 796 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2005 | 449 | 0.050 |
Why?
|
| NADP | 1 | 2024 | 223 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 1933 | 0.050 |
Why?
|
| Genes, Viral | 1 | 2004 | 650 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 2015 | 1753 | 0.050 |
Why?
|
| Prednisone | 2 | 2005 | 1565 | 0.050 |
Why?
|
| ras Proteins | 1 | 2008 | 1052 | 0.050 |
Why?
|
| Phenotype | 6 | 2013 | 16546 | 0.050 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2000 | 119 | 0.050 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 2003 | 332 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2007 | 938 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2013 | 2520 | 0.050 |
Why?
|
| Retroviridae | 2 | 2002 | 850 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 624 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 2290 | 0.050 |
Why?
|
| Dexamethasone | 2 | 2001 | 1927 | 0.050 |
Why?
|
| Brain Edema | 1 | 2007 | 603 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2003 | 459 | 0.050 |
Why?
|
| Oxygen | 1 | 2014 | 4193 | 0.050 |
Why?
|
| Versicans | 1 | 2021 | 40 | 0.050 |
Why?
|
| Immunologic Memory | 2 | 2007 | 1354 | 0.050 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2002 | 105 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2012 | 8056 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2005 | 693 | 0.050 |
Why?
|
| Blood | 1 | 2004 | 586 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 96 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2023 | 412 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2013 | 1528 | 0.050 |
Why?
|
| Transplantation Immunology | 1 | 2004 | 532 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1832 | 0.050 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2002 | 110 | 0.050 |
Why?
|
| Video Recording | 1 | 2007 | 955 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1846 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 1129 | 0.050 |
Why?
|
| Tetracycline | 1 | 2002 | 220 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2005 | 699 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 680 | 0.050 |
Why?
|
| Endothelial Growth Factors | 2 | 2002 | 673 | 0.050 |
Why?
|
| Integrins | 1 | 2005 | 839 | 0.050 |
Why?
|
| Herpesviridae Infections | 2 | 2002 | 270 | 0.050 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2001 | 92 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 1998 | 2316 | 0.050 |
Why?
|
| Ovary | 1 | 2005 | 958 | 0.050 |
Why?
|
| Prognosis | 6 | 2021 | 29658 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 232 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 2496 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2021 | 398 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2001 | 2234 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 49 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2021 | 254 | 0.050 |
Why?
|
| Pregnancy | 4 | 2014 | 29749 | 0.050 |
Why?
|
| Ritonavir | 1 | 2002 | 328 | 0.040 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2000 | 66 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 602 | 0.040 |
Why?
|
| Lymphokines | 2 | 2002 | 927 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2000 | 154 | 0.040 |
Why?
|
| Oocytes | 1 | 2005 | 1165 | 0.040 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 13262 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 2000 | 176 | 0.040 |
Why?
|
| Receptors, HIV | 1 | 2001 | 159 | 0.040 |
Why?
|
| Quinazolines | 1 | 2007 | 1363 | 0.040 |
Why?
|
| Thrombopoietin | 2 | 2008 | 226 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 2 | 1996 | 349 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2001 | 265 | 0.040 |
Why?
|
| Acetylation | 2 | 2013 | 1062 | 0.040 |
Why?
|
| Arteries | 2 | 2016 | 1126 | 0.040 |
Why?
|
| Genome | 1 | 2008 | 1739 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2004 | 835 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 1296 | 0.040 |
Why?
|
| Lung | 3 | 2015 | 9994 | 0.040 |
Why?
|
| Food Deprivation | 1 | 2020 | 114 | 0.040 |
Why?
|
| Gene Library | 1 | 2022 | 1060 | 0.040 |
Why?
|
| Leukocytes | 2 | 2019 | 2026 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2000 | 530 | 0.040 |
Why?
|
| Drugs, Generic | 1 | 2005 | 448 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 1994 | 4169 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2869 | 0.040 |
Why?
|
| Electricity | 1 | 2000 | 182 | 0.040 |
Why?
|
| Delavirdine | 1 | 1999 | 7 | 0.040 |
Why?
|
| PAX7 Transcription Factor | 1 | 2019 | 55 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 751 | 0.040 |
Why?
|
| Saquinavir | 1 | 1999 | 29 | 0.040 |
Why?
|
| Binding Sites | 1 | 2008 | 6048 | 0.040 |
Why?
|
| Membrane Fusion | 1 | 2001 | 266 | 0.040 |
Why?
|
| Connective Tissue Cells | 2 | 1996 | 50 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 869 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 306 | 0.040 |
Why?
|
| Ricin | 1 | 1998 | 70 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 438 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2021 | 11891 | 0.040 |
Why?
|
| Fever | 1 | 2006 | 1617 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2001 | 370 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4897 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1088 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2017 | 632 | 0.040 |
Why?
|
| Dyspnea | 1 | 2006 | 1352 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 234 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2009 | 1754 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2016 | 789 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 251 | 0.040 |
Why?
|
| Lymphoma, T-Cell | 1 | 2001 | 305 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2005 | 1355 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2001 | 375 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2002 | 740 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2000 | 318 | 0.040 |
Why?
|
| Endometrial Neoplasms | 1 | 2007 | 1357 | 0.040 |
Why?
|
| Thrombosis | 1 | 2012 | 3052 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 705 | 0.040 |
Why?
|
| Stavudine | 2 | 2012 | 84 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 108 | 0.040 |
Why?
|
| Interleukin-10 | 2 | 2011 | 1175 | 0.040 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2017 | 85 | 0.040 |
Why?
|
| Lac Operon | 1 | 1997 | 237 | 0.040 |
Why?
|
| Species Specificity | 3 | 2015 | 2418 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4048 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2003 | 749 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2018 | 140 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2005 | 1334 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1608 | 0.040 |
Why?
|
| Color | 1 | 2018 | 298 | 0.040 |
Why?
|
| Mitoguazone | 1 | 1997 | 11 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2002 | 1167 | 0.040 |
Why?
|
| Environment | 1 | 2003 | 1118 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1998 | 101 | 0.040 |
Why?
|
| Hygromycin B | 1 | 1996 | 11 | 0.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 251 | 0.040 |
Why?
|
| Lipopolysaccharides | 4 | 2008 | 2209 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 364 | 0.040 |
Why?
|
| Frontotemporal Dementia | 1 | 2020 | 246 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 655 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2012 | 1827 | 0.040 |
Why?
|
| Cytosol | 1 | 2000 | 887 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6238 | 0.030 |
Why?
|
| Rats | 3 | 2015 | 23711 | 0.030 |
Why?
|
| Leucovorin | 1 | 1998 | 641 | 0.030 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2016 | 25 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 622 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 747 | 0.030 |
Why?
|
| Connective Tissue | 2 | 1996 | 416 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2016 | 137 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 86 | 0.030 |
Why?
|
| California | 1 | 2001 | 1416 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9962 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 772 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2000 | 1351 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 1996 | 144 | 0.030 |
Why?
|
| Chemokines | 1 | 2001 | 962 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2001 | 1664 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 1996 | 286 | 0.030 |
Why?
|
| Thalidomide | 1 | 2021 | 884 | 0.030 |
Why?
|
| Lamivudine | 2 | 2012 | 363 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 2 | 2009 | 53 | 0.030 |
Why?
|
| Hodgkin Disease | 2 | 2001 | 1378 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1091 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2000 | 6498 | 0.030 |
Why?
|
| Transgenes | 1 | 1999 | 1006 | 0.030 |
Why?
|
| Transplantation Chimera | 2 | 2013 | 595 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1990 | 1249 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11847 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 928 | 0.030 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 1996 | 157 | 0.030 |
Why?
|
| Noonan Syndrome | 1 | 2016 | 120 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1996 | 286 | 0.030 |
Why?
|
| Candida albicans | 1 | 2019 | 374 | 0.030 |
Why?
|
| Homozygote | 1 | 2000 | 1788 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2019 | 552 | 0.030 |
Why?
|
| Simian immunodeficiency virus | 2 | 1998 | 805 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2000 | 732 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 1995 | 88 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2471 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2007 | 8986 | 0.030 |
Why?
|
| Adrenergic Fibers | 1 | 2014 | 21 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 341 | 0.030 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 1995 | 50 | 0.030 |
Why?
|
| Edema | 1 | 1999 | 769 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2016 | 292 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 365 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2012 | 5643 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1995 | 192 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 700 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2000 | 1368 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1657 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1793 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2014 | 108 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7475 | 0.030 |
Why?
|
| Lymphopenia | 1 | 1996 | 280 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 568 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12626 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5125 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 2014 | 158 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1994 | 422 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1999 | 1428 | 0.030 |
Why?
|
| Receptors, Thrombopoietin | 1 | 1995 | 161 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 719 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2001 | 935 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2014 | 195 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2014 | 189 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2016 | 289 | 0.030 |
Why?
|
| Poly A | 1 | 1994 | 181 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15757 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 13981 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2014 | 370 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 116 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1994 | 310 | 0.030 |
Why?
|
| Pericytes | 1 | 2016 | 293 | 0.030 |
Why?
|
| Thiazines | 1 | 2013 | 37 | 0.030 |
Why?
|
| Blastomeres | 1 | 2013 | 29 | 0.030 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2013 | 44 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 1998 | 857 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1996 | 803 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 204 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 848 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 296 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 678 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 1999 | 1300 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 459 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2001 | 1273 | 0.030 |
Why?
|
| Retroviridae Proteins | 2 | 1989 | 94 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2002 | 2415 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 2013 | 211 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4878 | 0.030 |
Why?
|
| Plasma | 1 | 2016 | 584 | 0.030 |
Why?
|
| Fetal Development | 1 | 2018 | 766 | 0.030 |
Why?
|
| HIV Antigens | 2 | 1990 | 325 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3804 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2013 | 225 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 1343 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2015 | 2981 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2013 | 433 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2013 | 189 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2852 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 21025 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2012 | 194 | 0.030 |
Why?
|
| Neurons | 2 | 2009 | 9426 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 378 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2020 | 1370 | 0.020 |
Why?
|
| Methotrexate | 1 | 1998 | 1719 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2014 | 900 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2000 | 3157 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3607 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2013 | 197 | 0.020 |
Why?
|
| Turpentine | 1 | 2011 | 10 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2007 | 3484 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 8158 | 0.020 |
Why?
|
| Glioma | 1 | 2006 | 3420 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 658 | 0.020 |
Why?
|
| Receptors, CCR1 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 1689 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1999 | 951 | 0.020 |
Why?
|
| Papio | 1 | 2013 | 661 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2018 | 1489 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 687 | 0.020 |
Why?
|
| Nevirapine | 1 | 2012 | 273 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12965 | 0.020 |
Why?
|
| Phylogeny | 1 | 1998 | 2775 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 116 | 0.020 |
Why?
|
| Aged | 9 | 2019 | 169152 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 480 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1999 | 2118 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1994 | 2299 | 0.020 |
Why?
|
| Administration, Intranasal | 2 | 2004 | 471 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2011 | 242 | 0.020 |
Why?
|
| Primary Myelofibrosis | 1 | 2013 | 210 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2013 | 226 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 998 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 97 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 835 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 443 | 0.020 |
Why?
|
| DNA | 4 | 2012 | 7233 | 0.020 |
Why?
|
| Doxycycline | 1 | 2012 | 341 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1167 | 0.020 |
Why?
|
| Cricetinae | 1 | 1994 | 2427 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1996 | 2608 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2004 | 3127 | 0.020 |
Why?
|
| Indoles | 1 | 2018 | 1829 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2013 | 358 | 0.020 |
Why?
|
| Genotype | 3 | 2013 | 12960 | 0.020 |
Why?
|
| Photons | 1 | 2014 | 581 | 0.020 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 368 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 1990 | 161 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 389 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4174 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1999 | 2299 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1995 | 1187 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 145 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1999 | 1454 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2001 | 1607 | 0.020 |
Why?
|
| Research Design | 1 | 2005 | 6180 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2011 | 277 | 0.020 |
Why?
|
| Liposomes | 3 | 1998 | 777 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 296 | 0.020 |
Why?
|
| Diet | 1 | 2007 | 8010 | 0.020 |
Why?
|
| Thrombopoiesis | 1 | 2011 | 164 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 418 | 0.020 |
Why?
|
| Nitriles | 1 | 2014 | 956 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2005 | 39261 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2014 | 716 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2002 | 748 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2313 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2020 | 1463 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 1990 | 915 | 0.020 |
Why?
|
| Retroviridae Infections | 1 | 1989 | 146 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Swine | 1 | 1999 | 5899 | 0.020 |
Why?
|
| Microdissection | 1 | 2009 | 151 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2013 | 522 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2012 | 409 | 0.020 |
Why?
|
| Benzamides | 1 | 2014 | 1369 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 885 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 354 | 0.020 |
Why?
|
| Immunization | 1 | 2013 | 1227 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 52 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2014 | 3663 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2105 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 616 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1993 | 1400 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2013 | 717 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1304 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2008 | 142 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1991 | 377 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2008 | 79 | 0.020 |
Why?
|
| Dendritic Cells | 2 | 2002 | 2725 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 1600 | 0.020 |
Why?
|
| Virion | 1 | 1990 | 421 | 0.020 |
Why?
|
| Rectum | 2 | 2003 | 895 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 1994 | 4319 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1998 | 2611 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3520 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 600 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1484 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4291 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 2005 | 5496 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1895 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 979 | 0.020 |
Why?
|
| South Africa | 1 | 2012 | 1821 | 0.020 |
Why?
|
| Femur | 1 | 2013 | 1302 | 0.020 |
Why?
|
| Sleep | 1 | 2022 | 4751 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 1045 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 575 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3616 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 878 | 0.020 |
Why?
|
| Sterilization, Reproductive | 1 | 2005 | 24 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 818 | 0.020 |
Why?
|
| Thiazoles | 1 | 2013 | 1511 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2002 | 41335 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2005 | 3969 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2005 | 216 | 0.020 |
Why?
|
| Obesity | 1 | 2007 | 12922 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 670 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 1526 | 0.020 |
Why?
|
| Oogenesis | 1 | 2005 | 124 | 0.020 |
Why?
|
| Virus Integration | 1 | 2007 | 302 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2004 | 42 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1182 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1991 | 1521 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2011 | 1006 | 0.010 |
Why?
|
| Bone Density | 1 | 2017 | 3534 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2004 | 52 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 8469 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 1993 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2014 | 2860 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1998 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1529 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4419 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 915 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2013 | 2907 | 0.010 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2005 | 263 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 2203 | 0.010 |
Why?
|
| Administration, Oral | 2 | 2002 | 4035 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22053 | 0.010 |
Why?
|
| Testosterone | 1 | 2014 | 2470 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1493 | 0.010 |
Why?
|
| Self Administration | 1 | 2004 | 390 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1347 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 666 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2005 | 877 | 0.010 |
Why?
|
| E-Selectin | 1 | 2005 | 576 | 0.010 |
Why?
|
| Exercise | 1 | 2019 | 5787 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2003 | 228 | 0.010 |
Why?
|
| Probenecid | 1 | 2002 | 73 | 0.010 |
Why?
|
| Coronary Care Units | 1 | 1984 | 235 | 0.010 |
Why?
|
| Autophagy | 1 | 2010 | 1337 | 0.010 |
Why?
|
| Drug Carriers | 2 | 1998 | 709 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4611 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 321 | 0.010 |
Why?
|
| Africa South of the Sahara | 1 | 2005 | 742 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2008 | 897 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 2005 | 467 | 0.010 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2002 | 71 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2006 | 775 | 0.010 |
Why?
|
| Tetracyclines | 1 | 2002 | 65 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2003 | 362 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2003 | 5201 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2002 | 133 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 419 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2004 | 713 | 0.010 |
Why?
|
| Perforin | 1 | 2002 | 167 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7408 | 0.010 |
Why?
|
| Hypertension | 1 | 2021 | 8594 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2002 | 183 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2001 | 173 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 452 | 0.010 |
Why?
|
| Indinavir | 1 | 2001 | 73 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 128 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 1171 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 1446 | 0.010 |
Why?
|
| Etoposide | 1 | 2002 | 630 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 458 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 898 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2007 | 869 | 0.010 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2000 | 16 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1999 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2002 | 226 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 2001 | 184 | 0.010 |
Why?
|
| Placebos | 1 | 2004 | 1668 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2002 | 369 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2002 | 461 | 0.010 |
Why?
|
| Gels | 1 | 2000 | 419 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1999 | 192 | 0.010 |
Why?
|
| Zebrafish | 1 | 2011 | 2997 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2000 | 202 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4107 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 1999 | 242 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 814 | 0.010 |
Why?
|
| Paresthesia | 1 | 2000 | 162 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 1745 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2005 | 2897 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 1055 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2000 | 713 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 1023 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3334 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1173 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2000 | 377 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1999 | 728 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1385 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1999 | 526 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 1998 | 208 | 0.010 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 103 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80372 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 1889 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 1148 | 0.010 |
Why?
|
| Magnetics | 1 | 2000 | 600 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1992 | 14660 | 0.010 |
Why?
|
| Nausea | 1 | 2000 | 678 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5794 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 543 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 1893 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1998 | 564 | 0.010 |
Why?
|
| Calcimycin | 1 | 1995 | 213 | 0.010 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1994 | 75 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1992 | 20080 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2221 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 58741 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 1996 | 559 | 0.010 |
Why?
|
| Fatigue | 1 | 2000 | 1544 | 0.010 |
Why?
|
| Developing Countries | 1 | 2005 | 2868 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7269 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2004 | 2044 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1998 | 3105 | 0.010 |
Why?
|
| Alopecia | 1 | 1996 | 414 | 0.010 |
Why?
|
| Headache | 1 | 2000 | 1249 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 3022 | 0.010 |
Why?
|
| Child | 1 | 2019 | 79806 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 87810 | 0.010 |
Why?
|
| Canada | 1 | 1996 | 2128 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12427 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 6771 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1996 | 2648 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 1994 | 719 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 8950 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1989 | 58 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 866 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1984 | 5990 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1989 | 224 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1992 | 915 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2325 | 0.000 |
Why?
|
| Melanoma | 1 | 2005 | 5697 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36290 | 0.000 |
Why?
|
| DNA Replication | 1 | 1992 | 1412 | 0.000 |
Why?
|
| Recurrence | 1 | 1997 | 8482 | 0.000 |
Why?
|
| Hospital Units | 1 | 1984 | 142 | 0.000 |
Why?
|
| United States | 3 | 2000 | 72461 | 0.000 |
Why?
|
| Prospective Studies | 2 | 1998 | 54303 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1989 | 1791 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 25942 | 0.000 |
Why?
|
| Quality of Life | 1 | 2002 | 13308 | 0.000 |
Why?
|
| Angina Pectoris | 1 | 1984 | 969 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 58995 | 0.000 |
Why?
|
| Probability | 1 | 1984 | 2475 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1989 | 2276 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1984 | 2781 | 0.000 |
Why?
|
| Risk | 1 | 1984 | 9631 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1984 | 5508 | 0.000 |
Why?
|